More about

Interleukin 1

Clinical Guidance
Rheumatoid Arthritis
Treatment Options

Interleukin-6 Inhibitors

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Rheumatoid Arthritis
Treatment Options

Interleukin-1 Inhibition

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Gout
Assessment and Treatment

Prophylaxis of Acute Gout Flares

Robert Terkeltaub, MD; N. Lawrence Edwards, MD, MACP, MACR; Puja Khanna, MD, MPH

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
July 26, 2022
44 min listen
Save

SAPHO Part 2: An Abundance of Acronyms

SAPHO Part 2: An Abundance of Acronyms

What does the PAPA spectrum disorder teach us about SAPHO? Is SAPHO an autoinflammatory condition or part of the SpA spectrum? Why have antibiotics been used to treat this condition? Find out in this episode!

News
July 19, 2022
4 min read
Save

Interleukin-1 mediated autoinflammatory diseases call for IL-1 blockers, steady monitoring

Interleukin-1 mediated autoinflammatory diseases call for IL-1 blockers, steady monitoring

Diagnostic workups for patients with interleukin-1 mediated autoinflammatory diseases should include an audiogram and ophthalmic examination, according to data published in the Annals of the Rheumatic Diseases.

News
February 25, 2021
1 min read
Save

Interleukin-1 receptor antagonist plasma levels correlate with neurofilament light, disability in MS

Plasma levels of interleukin-1 receptor antagonist correlated with cerebrospinal fluid neurofilament light levels and predicted disability among patients with MS, according to a study presented at the ACTRIMS virtual meeting.

News
February 23, 2021
3 min read
Save

IL-1 inhibitors linked to ‘significant reduction’ in COVID-19 mortality

IL-1 inhibitors linked to ‘significant reduction’ in COVID-19 mortality

Interleukin-1 inhibitors are associated with a “significant reduction” in mortality among patients hospitalized with COVID-19, respiratory insufficiency and hyperinflammation, according to data published in The Lancet Rheumatology.